AbbVie (ABBV)

R&D Expenses

$2.34B

Quarterly · Period ending: · USD

ABBV logo

ABBV R&D Expenses

Latest reported$2.34B
ABBV Quarterly R&D Expenses ($587.10M → $2.34B)
High-resolution chart · PNG

ABBV r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AbbVie R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
2,344,000,000
2,472,000,000
2,579,000,000
2,319,000,000
2,131,000,000
2,067,000,000
6,774,000,000
2,130,000,000
1,948,000,000
1,939,000,000
2,209,000,000
1,723,000,000
1,733,000,000
2,292,000,000
2,033,000,000
1,654,000,000
1,878,000,000
1,642,000,000
2,232,000,000
2,063,000,000
1,899,000,000
1,852,000,000
2,190,000,000
1,751,000,000
2,435,000,000
1,379,000,000
1,681,000,000
2,285,000,000
1,382,000,000
1,444,000,000
6,795,000,000
1,323,000,000
1,322,000,000
1,313,000,000
1,714,000,000
1,228,000,000
1,244,000,000
1,142,000,000
1,230,000,000
1,186,000,000
1,194,000,000
956,000,000
1,075,000,000
1,418,000,000
1,004,000,000
938,000,000
907,000,000
1,120,000,000
850,000,000
772,000,000
846,000,000
934,000,000
779,000,000
634,000,000
969,221,000
813,000,000
752,000,000
792,000,000
775,129,000
665,521,000
589,759,000
587,097,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.